Literature DB >> 9646227

Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties.

J Soga1.   

Abstract

This study aimed at obtaining a better understanding of the malignant characteristics of carcinoids (gut endocrinomas) of the digestive system. After excluding cases with no possible individual identification as for age and sex, 2001 carcinoid cases with metastases among 5647 of the digestive system computerized in the Niigata Registry were thus subject to the present analysis. These cases were divided into two groups: [A] 1719 with ordinary carcinoid histology and [B] 282 with atypical varieties including argyrophil (endocrine) cell carcinomas, small/oat cell carcinomas of endocrine type, composite carcinoid-adenocarcinoma varieties and other neuroendocrine tumors. In many aspects, a comparative analysis demonstrated statistical differences between [A] and [B]: average age (55.7 vs 60.1), the rates of metastases (34.4% vs 55.6%), the association of carcinoid syndrome (21.4% vs 2.8%), tumor size 20mm or less (42.2% vs 22.5%), depth of invasion down to the submucosa (21.6% vs 11.7%) and transmural invasion (34.3% vs 47.7%), immunohistochemistry of neuron-specific enolase (86.5% vs 66.7%), chromogranin (86.1% vs 67.6%), vasointestinal polypeptides, ACTH and alpha-fetoprotein, and the 5-year survival rate (61.4% vs 17.9%). No statistical differences between these two groups were found in the male to female ratio, serotonin activities and Grimelius argyrophilia. Although no generally acceptable definite criteria and definition for atypical carcinoid varieties have yet established, neoplasias of this category seem to have a wide range of histological, histochemical, immunohistochemical, ultrastructural and biochemical features that may mostly be placed in between ordinary carcinoids and ordinary carcinomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9646227

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  14 in total

1.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.

Authors:  J K Ramage; A H G Davies; J Ardill; N Bax; M Caplin; A Grossman; R Hawkins; A M McNicol; N Reed; R Sutton; R Thakker; S Aylwin; D Breen; K Britton; K Buchanan; P Corrie; A Gillams; V Lewington; D McCance; K Meeran; A Watkinson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

2.  Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: response to chemotherapy and octreotide LAR.

Authors:  L Tauchmanovà; M Pensabene; I Capuano; I Spagnoletti; P Zeppa; S Del Vecchio; M Mainenti; G De Rosa; A Colao; A Contegiacomo
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

3.  Carcinoid tumors of the appendix - last decade experience.

Authors:  Kleanthis Anastasiadis; Chrysostomos Kepertis; Vasilios Lampropoulos; Paschalis Tsioulas; Ioannis Spyridakis
Journal:  J Clin Diagn Res       Date:  2014-11-20

4.  Clinicopathological evaluation of duodenal well-differentiated endocrine tumors.

Authors:  Kenji Ishido; Satoshi Tanabe; Katsuhiko Higuchi; Tohru Sasaki; Chikatoshi Katada; Mizutomo Azuma; Akira Naruke; Wasaburo Koizumi; Tetsuo Mikami
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

Review 5.  Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data.

Authors:  Susan Shamimi-Noori; Carin F Gonsalves; Colette M Shaw
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

6.  Hepatic metastatic disease in pediatric and adolescent solid tumors.

Authors:  Israel Fernandez-Pineda; John A Sandoval; Andrew M Davidoff
Journal:  World J Hepatol       Date:  2015-07-18

Review 7.  Multimodal management of neuroendocrine liver metastases.

Authors:  Andrea Frilling; Georgios C Sotiropoulos; Jun Li; Oskar Kornasiewicz; Ursula Plöckinger
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

8.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).

Authors:  John K Ramage; A Ahmed; J Ardill; N Bax; D J Breen; M E Caplin; P Corrie; J Davar; A H Davies; V Lewington; T Meyer; J Newell-Price; G Poston; N Reed; A Rockall; W Steward; R V Thakker; C Toubanakis; J Valle; C Verbeke; A B Grossman
Journal:  Gut       Date:  2011-11-03       Impact factor: 23.059

9.  Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours.

Authors:  G Yadegarfar; L Friend; L Jones; L M Plum; J Ardill; B Taal; G Larsson; K Jeziorski; D Kwekkeboom; J K Ramage
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

10.  Duodenal somatostatinoma: a case report and review of the literature.

Authors:  Oguz Koc; Yigit Duzkoylu; Yavuz Selim Sari; Hasan Bektas; Gungor Uzum; Vahit Tunali; Esra Pasaoglu
Journal:  J Med Case Rep       Date:  2013-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.